FDA Approval for Pivotal Trial of Innovative JuxtaFlow® Renal Assist Device Marks Significant Milestone in Kidney Health Roivios announces FDA IDE approval for the pivotal trial of its JuxtaFlow Renal Assist Device, aimed at improving outcomes in kidney health for cardiac surgery patients.

FDA Approval for Pivotal Trial of Innovative JuxtaFlow® Renal Assist Device Marks Significant Milestone in Kidney Health #USA #FDA_Approval #Nassau #JuxtaFlow_RAD #Roivios